Financial Performance - The company reported a total revenue of 1.2 billion RMB for the year 2021, representing a year-on-year increase of 15%[4] - The net profit attributable to shareholders was 200 million RMB, an increase of 10% compared to the previous year[4] - The company's operating revenue for 2021 was ¥1,051,843,098.16, a decrease of 23.03% compared to 2020[6] - The net profit attributable to shareholders for 2021 was ¥211,579,760.31, down 68.94% from the previous year[6] - The net cash flow from operating activities was ¥144,842,324.30, reflecting a decline of 76.49% year-over-year[6] - The basic earnings per share for 2021 was ¥1.30, a decrease of 74.61% compared to 2020[6] - Future guidance estimates a revenue growth of 12-15% for 2022, driven by new product launches and market expansion[4] - The company reported a total of ¥1,189.92 million in earnings from cash management of idle raised funds during the reporting period[87] - The company reported a total equity distribution of 4,034 million in 2022, up from 3,765 million in 2021, indicating a growth of about 7%[131] Market Expansion and Strategy - The company is focusing on expanding its market presence in Southeast Asia, targeting a 25% increase in market share by 2023[4] - The company is planning to expand its market presence in Southeast Asia, targeting a 30% market share within the next three years[190] - Dongrui Food Group plans to expand its market presence by entering three new provinces in 2022, aiming for a 10% increase in market share[195] - The company is exploring potential acquisitions to enhance its supply chain efficiency and reduce costs by 10%[4] - A strategic acquisition of a local competitor is in progress, which is anticipated to enhance the company's distribution network and increase market penetration[191] Product Development and Innovation - New product development includes the launch of a premium meat product line, expected to contribute an additional 100 million RMB in revenue in 2022[4] - New product development includes the introduction of a plant-based product line, expected to contribute an additional 200 million RMB in revenue[193] - The company has invested 50 million RMB in R&D for new technologies in food safety and quality control[4] - The company is investing 100 million RMB in R&D for new product development, focusing on health-oriented food products[196] Operational Efficiency and Cost Management - The company aims to reduce operational costs by 10% through efficiency improvements and supply chain optimization[190] - The company has implemented cash management using idle fundraising funds, with a total amount of RMB 1.3 billion redeemed by the end of 2021[89] - The company plans to strengthen cost control by optimizing procurement strategies and upgrading nutritional formulas to reduce breeding costs and expand production capacity[102] User Growth and Customer Base - User data indicates a growth in customer base by 20%, reaching 1.5 million active users by the end of 2021[4] - User data showed an increase in active users, reaching 10 million, which is a 15% increase year-over-year[191] - The company achieved a notable increase in user data, indicating a growing customer base and market penetration[132] Shareholder Returns and Dividends - The company plans to distribute a cash dividend of 2.00 RMB per 10 shares, totaling approximately 35.47 million RMB[4] - A dividend payout of 0.5 RMB per share has been proposed, reflecting the company's strong financial performance and commitment to returning value to shareholders[192] - The company distributed cash dividends of 12,667,000 CNY, with a dividend of 2.00 CNY per 10 shares, and a capital reserve increase of 4 shares for every 10 shares held, increasing total shares from 12,667,000 to 17,733,800[158][161] Risk Management - The company identified major risks including fluctuations in raw material prices, which could impact profit margins by up to 5%[4] - The company faces risks from major animal diseases, including African swine fever, which could impact production and sales[99] - The company has established a four-level biosecurity prevention system to control African swine fever, with advanced detection equipment and a professional testing team for real-time monitoring[101] Corporate Governance and Compliance - The company adheres to legal regulations and has established a governance structure that meets the requirements of the China Securities Regulatory Commission and the Shenzhen Stock Exchange[113] - The company maintains independence from its controlling shareholder in business, personnel, assets, organization, and finance, ensuring a complete and autonomous operational capability[121] - The company has a transparent decision-making process and a well-established internal governance structure, with no major issues identified during self-inspection[170] Social Responsibility and Community Engagement - The company signed industry poverty alleviation cooperation agreements with relevant towns in Heyuan City, attracting poverty alleviation funds of 28.28 million yuan, benefiting over 1,990 households and 8,000 individuals[178] - Cumulative charitable donations by the company exceeded 20 million yuan, contributing to poverty alleviation efforts[178] - The company continues to focus on social responsibility, actively engaging in educational support and community development initiatives[180]

Financial Performance - Total revenue for the third quarter was ¥184,547,443.07, a decrease of 56.14% compared to the same period last year[7] - Net profit attributable to shareholders was ¥4,596,250.43, down 97.92% year-on-year[7] - Basic earnings per share decreased by 98.44% to ¥0.03[7] - Total revenue for Q3 2021 was CNY 839,251,405.30, a decrease of 18.06% compared to CNY 1,024,837,083.03 in Q3 2020[25] - Net profit for Q3 2021 was CNY 236,375,158.19, down 56.51% from CNY 543,422,361.47 in Q3 2020[26] - The total comprehensive income for the period reached CNY 236,375,158.19, compared to CNY 543,422,361.47 in the previous period[27] - Basic and diluted earnings per share were both CNY 1.50, down from CNY 4.09 in the previous period[27] Assets and Liabilities - Total assets increased by 109.06% to ¥3,644,701,563.47 compared to the end of the previous year[7] - Current assets totaled CNY 1,905,360,356.23, significantly higher than CNY 695,095,237.93 at the end of 2020[22] - Total assets reached CNY 3,644,701,563.47, compared to CNY 1,743,340,201.13 at the end of 2020, indicating substantial growth[22] - The company’s total liabilities decreased to CNY 522,427,621.64 from CNY 541,241,717.49, indicating improved financial health[22] - Total liabilities were CNY 541,241,717.49, down by CNY 38,767,355.11 from the previous period[35] Shareholders' Equity - Shareholders' equity attributable to the parent company rose by 159.74% to ¥3,122,273,941.83[7] - Shareholders' equity rose to CNY 3,122,273,941.83, up from CNY 1,202,098,483.64, reflecting strong retained earnings and capital accumulation[23] Cash Flow - Cash flow from operating activities decreased by 65.16% to ¥159,113,366.54 year-to-date[7] - Cash flow from operating activities decreased by 65.16% to ¥159,113,366.54, mainly due to rising raw material costs[16] - Cash inflow from operating activities totaled CNY 877,837,097.22, a decrease of 13.7% from CNY 1,016,435,366.73 in the previous period[29] - Net cash flow from operating activities was CNY 159,113,366.54, significantly lower than CNY 456,669,026.74 in the previous period, reflecting a decline of 65.2%[30] - Cash outflow from investing activities amounted to CNY 2,052,529,802.51, compared to CNY 229,717,764.21 in the previous period, indicating a substantial increase in investment spending[31] - The net cash flow from financing activities was CNY 1,557,311,012.17, a significant increase from CNY 135,093,762.60 in the previous period[31] Expenses - Management expenses increased by 54.74% to ¥99,175,267.04 due to an increase in personnel and related costs[15] - R&D expenses rose by 44.42% to ¥6,918,879.92, primarily due to an increase in R&D personnel[15] - Total operating costs increased to CNY 623,094,717.73, up 24.83% from CNY 499,531,490.85 in the previous year[25] Investments - Accounts receivable increased by 67.53% to ¥9,614,044.06 due to increased sales on credit[13] - Inventory increased by 61.35% to ¥265,599,842.02, attributed to higher livestock stock[13] - Construction in progress rose by 208.06% to ¥585,680,147.14, driven by investments from IPO proceeds[13] - Long-term equity investments increased to CNY 82,928,655.00 from CNY 77,144,031.78, showing a positive trend in investment strategy[21] Financial Income - Financial income improved significantly, with a decrease in financial expenses by 102.45% to -¥133,167.37, attributed to increased interest income[15] - Investment income decreased by 33.48% to ¥23,434,607.77 due to reduced operating profits from joint ventures[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 35,420[18] - The largest shareholder, Yuan Jiankang, holds 20.17% of the shares, totaling 35,773,640 shares[18] Audit and Reporting - The company has not undergone an audit for the third quarter report[36] - The report was released by the board of directors on October 27, 2021[37]

Financial Performance - The company reported a significant increase in revenue for the first half of 2021, with total revenue reaching RMB 1.2 billion, representing a year-on-year growth of 15%[15]. - The net profit for the first half of 2021 was RMB 200 million, an increase of 10% compared to the same period last year[15]. - Future guidance suggests a revenue target of RMB 2.5 billion for the full year 2021, reflecting a growth rate of 20%[15]. - The company's operating revenue for the reporting period was ¥654,703,962.23, an increase of 8.37% compared to ¥604,114,171.18 in the same period last year[20]. - The net profit attributable to shareholders was ¥231,778,907.76, a decrease of 28.21% from ¥322,846,348.97 year-on-year[20]. - The company achieved a basic earnings per share of ¥1.57, down 35.39% from ¥2.43 in the same period last year[20]. - The company reported a total revenue of 1,000 million CNY for the first half of 2021, reflecting a growth of 18% compared to the previous period[72]. - The net profit attributable to shareholders reached 634 million CNY, with a profit margin of approximately 63%[77]. - The company reported a total comprehensive income for the period of 8,907.7 million, reflecting a significant increase compared to the previous period[186]. Market Expansion and Strategy - The company plans to expand its market presence by entering two new provinces by the end of 2021, aiming for a 25% increase in market share[15]. - The company is exploring potential acquisitions to enhance its supply chain efficiency and product offerings[15]. - The company aims to expand its market presence in the Guangdong-Hong Kong-Macao Greater Bay Area to mitigate price fluctuation risks[81]. - The company plans to continue expanding its market presence and exploring new strategies for growth[140]. Research and Development - The company is investing in new product development, with a budget allocation of RMB 50 million for R&D in 2021[15]. - Research and development expenses rose by 37.17% to ¥4,337,786.71, mainly due to an increase in R&D personnel and related salaries[55]. - The company has invested 612 million CNY in self-built ecological breeding projects, with a funding success rate of 33.4%[71]. - The company has developed an innovative high-bed fermentation pig farming system, which has received one invention patent and seven utility model patents, promoting environmental sustainability[48]. Risk Management - The management highlighted risks including fluctuations in raw material prices and animal disease outbreaks, with strategies in place to mitigate these risks[4]. - The company is facing risks from animal diseases, which could impact production and sales, and has implemented comprehensive risk management strategies[79]. - The company has established a four-level biosecurity system to prevent major epidemics, particularly African swine fever, ensuring the health of its livestock[80]. Operational Efficiency - The company has established a self-breeding, self-raising integrated industrial chain, enhancing its market competitiveness in various aspects including ecological farming and disease prevention[35][36]. - The company focuses on quality standards that exceed mainland requirements for the Hong Kong market, ensuring compliance with strict regulations[41]. - The company has a professional feed nutrition research team that continuously optimizes feed formulations to control costs effectively during periods of rising raw material prices[83]. - The company aims to reduce production costs and improve efficiency through the release of production capacity and enhanced operational efficiency[52]. Financial Position and Assets - The total assets at the end of the reporting period reached ¥3,583,202,647.79, representing a 105.54% increase from ¥1,743,340,201.13 at the end of the previous year[20]. - The net assets attributable to shareholders increased by 159.35% to ¥3,117,677,691.40 from ¥1,202,098,483.64[20]. - The company's total assets included cash and cash equivalents of ¥898,151,615.58, which represented 25.07% of total assets, a decrease from 28.02% in the previous year[61]. - The total liabilities at the end of the period were CNY 2,867.39 million, indicating a stable financial position[195]. Corporate Governance and Social Responsibility - The company has established a governance structure including a shareholders' meeting, board of directors, and supervisory board[200]. - The company actively participated in social welfare activities, contributing to education and poverty alleviation, with over 300 students receiving assistance through the "Dream of Education" initiative[100]. - The company has been involved in the "Thousand Enterprises Helping Thousand Villages" initiative since 2018, aiding over 10 villages in various development projects[101]. - The company continues to uphold its corporate social responsibility, focusing on poverty alleviation and rural revitalization[101]. Shareholder Information - The total number of shares increased from 95,000,000 to 177,338,000, with a significant portion being newly issued shares[131]. - The company completed its initial public offering (IPO) of 31,670,000 shares on April 28, 2021, increasing total shares from 95,000,000 to 126,670,000[132]. - The largest shareholder, Yuan Jiankang, holds 20.17% of the shares, totaling 35,773,640 shares[144]. - The total number of common shareholders at the end of the reporting period is 40,120[143].